Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor αβ lineage

被引:96
作者
Szczepanski, T
Pongers-Willemse, MJ
Langerak, AW
Harts, WA
Wijkhuijs, AJM
van Wering, ER
van Dongen, JJM
机构
[1] Erasmus Univ, Univ Rotterdam Hosp, Dept Immunol, NL-3000 DR Rotterdam, Netherlands
[2] Med Univ Silesia, Dept Pediat Hematol & Chemotherapy, Zabrze, Poland
[3] Dutch Childhood Leukemia Study Grp, The Hague, Netherlands
关键词
D O I
10.1182/blood.V93.12.4079.412k42_4079_4085
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rearranged IGH genes were detected by Southern blotting in 22% of 118 cases of T-cell acute lymphoblastic leukemia (ALL) and involved monoallelic and biallelic rearrangements in 69% (18/26) and 31% (8/26) of these cases, respectively. IGH gene rearrangements were found in 19% (13/69) of CD3(-) T-ALL and in 50% of TCR gamma delta(+) T-ALL (12/24), whereas only a single TCR alpha beta(+) T-ALL (1/25) displayed a monoallelic IGH gene rearrangement. The association with the T-cell receptor (TCR) phenotype was further supported by the striking relationship between IGH and TCR delta (TCRD) gene rearrangements, ie, 32% of T-ALL (23/72) with monoallelic or biallelic TCRD gene rearrangements had IGH gene rearrangements, whereas only 1 of 26 T-ALL with biallelic TCRD gene deletions contained a monoallelic IGH gene rearrangement. Heteroduplex polymerase chain reaction (PCR) analysis with VH and DH family-specific primers in combination with a JH consensus primer showed a total of 39 clonal products, representing 7 (18%) VH-(DH-)JH joinings and 32 (82%) DH-JH rearrangements. Whereas the usage of VH gene segments was seemingly random, preferential usage of DH6-19 (45%) and DH7-27 (21%) gene segments was observed. Although the JH4 and JH6 gene segments were used most frequently (33% and 21%, respectively), a significant proportion of joinings (28%) used the most upstream JH1 and JH2 gene segments, which are rarely used in precursor-B-ALL and normal B cells (1% to 4%). In conclusion, the high frequency of incomplete DH-JH rearrangements, the frequent usage of the more downstream DH6-19 and DH7-27 gene segments, and the most upstream JH1 and JH2 gene segments suggests a predominance of immature IGH rearrangements in immature (non-TCR alpha beta(+)) T-ALL as a result of continuing V(D)J recombinase activity. More mature cup-lineage T-ALL with biallelic TCRD gene deletions apparently have switched off their recombination machinery and are less prone to crosslineage IGH gene rearrangements. The combined results indicate that IGH gene rearrangements in T-ALL are post-oncogenic processes, which are absent in T-ALL with deleted TCRD genes and completed TCR alpha (TCRA) gene rearrangements. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:4079 / 4085
页数:7
相关论文
共 53 条
[1]  
ADRIAANSEN HJ, 1991, LEUKEMIA, V5, P744
[2]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[3]  
AUBIN J, 1995, LEUKEMIA, V9, P471
[4]   ANALYSIS OF IG AND T-CELL RECEPTOR GENES IN 40 CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAS AT DIAGNOSIS AND SUBSEQUENT RELAPSE - IMPLICATIONS FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE BY POLYMERASE CHAIN-REACTION ANALYSIS [J].
BEISHUIZEN, A ;
VERHOEVEN, MAJ ;
VANWERING, ER ;
HAHLEN, K ;
HOOIJKAAS, H ;
VANDONGEN, JJM .
BLOOD, 1994, 83 (08) :2238-2247
[5]  
BEISHUIZEN A, 1993, LEUKEMIA, V7, P2045
[6]   Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias:: a new molecular target for detection of minimal residual disease [J].
Beishuizen, A ;
de Bruijn, MAC ;
Pongers-Willemse, MJ ;
Verhoeven, MAJ ;
van Wering, ER ;
Hählen, K ;
Breit, TM ;
de Bruin-Versteeg, S ;
Hooijkaas, H ;
van Dongen, JJM .
LEUKEMIA, 1997, 11 (12) :2200-2207
[7]   Ig D-H gene segment transcription and rearrangement before surface expression of the pan-B cell marker CD19 in normal human bone marrow [J].
Bertrand, FE ;
Billips, LG ;
Burrows, PD ;
Gartland, GL ;
Kubagawa, H ;
Schroeder, HW .
BLOOD, 1997, 90 (02) :736-744
[8]  
Bertrand FE, 1996, J IMMUNOL, V156, P4240
[9]  
BIONDI A, 1990, BLOOD, V75, P1834
[10]  
BORN W, 1988, J IMMUNOL, V140, P3228